SCHEMBL7646111

SCHEMBL7646111

CCCOc1cc(I)ccc1C(C)=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA9 Q16790 2/20 0.51
LMNA P02545 6/20 0.46
MAPT P10636 5/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
SMN1; SMN2 Q16637 3/20 0.45
KDM4E B2RXH2 2/20 0.45
ALDH1A1 P00352 2/20 0.45
CYP3A4 P08684 1/20 0.45
TSHR P16473 1/20 0.45
CYSLTR2 Q9NS75 1/20 0.43
CYSLTR1 Q9Y271 1/20 0.43
CYP1A2 P05177 2/20 0.42
CYP2D6 P10635 1/20 0.42
SCN1A P35498 1/20 0.42
SCN2A Q99250 1/20 0.42
SCN3A Q9NY46 1/20 0.42
MAOB P27338 1/20 0.40
POLB P06746 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC8 Q9BY41 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3743259 0.84 TDP1 (0.49) CA9MAPTL3MBTL1SMN1; SMN2KDM4E
SCHEMBL15087904 0.84 LMNA (0.47) LMNAMAPTL3MBTL1SMN1; SMN2KDM4E
SCHEMBL8218438 0.83 LMNA (0.55) CA9LMNAMAPTL3MBTL1SMN1; SMN2
SCHEMBL23267707 0.82 SMN1; SMN2 (0.56) CA9LMNAMAPTL3MBTL1SMN1; SMN2
SCHEMBL12121589 0.81 TP53 (0.50) KDM4ETSHRPPARGPPARA
SCHEMBL17973685 0.81 PTGDR2 (0.51) CA9LMNAMAPTL3MBTL1SMN1; SMN2
SCHEMBL7646661 0.78 HPGD (0.50) CA9LMNAMAPTL3MBTL1SMN1; SMN2
SCHEMBL10047544 0.78 TDP1 (0.49) MAPTL3MBTL1SMN1; SMN2KDM4EALDH1A1
SCHEMBL5960630 0.78 HTT (0.48) CA9LMNAMAPTSMN1; SMN2KDM4E
SCHEMBL8478888 0.77 PTPN11 (0.51) MAPTKDM4EALDH1A1TSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6479520-B1 REGULATING APOPTOSIS IN HUMAN CELLS WITH COMPOUNDS SUCH AS: 3-CYANO-6-(2-METHOXY-4-METHYLTHIOIPHENYL)-2(1H)-PYRIDINONE CELL PATHWAYS, INC. 2002-11-12 US disclosed
US-6046216-A USEFUL TO INHIBIT THE GROWTH OF NEOPLASTIC CELLS. CELL PATHWAYS, INC. (US) 2000-04-04 US disclosed
EP-0428268-A2 Pharmaceutical phenylpyridone derivatives SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1991-05-22 EP disclosed